Insulet (NASDAQ: PODD) reported Q2 EPS of $1.17, $0.25 better than the analyst estimate of $0.92. Revenue for the quarter came in at $649.1 million versus the consensus estimate of $614.18 million.

For earnings history and earnings-related data on Insulet (PODD) click here.